Our Mission is to rewrite the model of what's possible to drive life forward

Technology and biology are coming together to amplify each other in profound ways.

We work on the ground level to galvanize the industry around this fast-growing field and form long-term partnerships with entrepreneurs inventing the future.

We are not just capital allocators, but company builders, scientists, and engineers.

Our philosophy is informed by our experience founding, building, and investing in successful biotech, hardware, and software platforms. We seek to mirror the founders who will define the next generation of the life sciences with native fluency across the continuum of chemistry, biology, software, machine learning, and automation.

Our approach is purpose-built for the sector.

Investing across platforms, software, and tools
Flexibility to invest across stages
Founder-centric partnership model
Fundamental research in science, technology, and markets
Long-term oriented to unlock compounding value of platforms
Global reach

Our team

Adam Goulburn, PhD
Founder & Managing Partner
Adam Goulburn, PhD
Nan Li
Founder & Managing Partner
Nan Li
Zavain Dar
Founder & Managing Partner
Zavain Dar
Simon Barnett
Research Director
Simon Barnett
Eric Dai
Investor
Eric Dai
Michele Vlcek
Operations Manager
Michele Vlcek
Amy Zhen
Sr. Executive Assistant
Amy Zhen
Investing in Kimia Therapeutics
Investing in Kimia Therapeutics

Investing in Automata
Investing in Automata

Welcoming Eric Dai to the Investment Team
Welcoming Eric Dai to the Investment Team

Announcing Simon Barnett as Research Director
Announcing Simon Barnett as Research Director